483 Glaxo Wellcome Manufacturing Pte Jun 2018

483 Glaxo Wellcome Manufacturing Pte Jun 2018

Jose Melendez FDA$119.00 - Available Now

FDA investigators audited the Glaxo Wellcome Manufacturing Pte - Singapore, Singapore facility and issued inspectional observations (via FDA 483) on 01 Jun 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Jun 2018
  • Location: Singapore, Singapore
  • FEI: 3002807079
Add To Cart